Business

The FINANCIAL -- Novartis on July 21 announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of Rydapt (midostaurin) for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) who are FLT3 ...

More Articles ...

More Articles ...

The FINANCIAL -- Merck, Pfizer and Corning Incorporated on July 20 announced collaborations that have enabled the modernization of pharmaceutical packaging with the introduction of Corning Valor ...

The FINANCIAL -- GSK on July 21 announces that Dr Laurie Glimcher has been appointed to the Board of the Company as a Non-Executive Director and has been deemed a Scientific and Medical ...